AZZ (AZZ) vs Establishment Labs (ESTA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Establishment Labs (ESTA) has outperformed AZZ (AZZ) over the past year, gaining 51.1% versus a gain of 28.7%. Over five years, AZZ leads with a +155.9% price change compared with -21.3% for ESTA. AZZ is the larger company by market cap ($4.12 billion vs $1.83 billion), about 2.3 times the size, while Establishment Labs is growing revenue faster (+27.1% vs +4.6%).
On valuation, AZZ trades at a lower forward P/E (17.6x vs 1022.5x for Establishment Labs). AZZ pays a dividend yielding 0.58%, while Establishment Labs does not currently pay one. AZZ converts more of its revenue into profit, with a net margin of 19.2% versus -24.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AZZ | ESTA |
|---|---|---|
| Share price | $137.13 | $61.35 |
| Market cap | $4.12B | $1.83B |
| 1-day change | +0.55% | +1.22% |
| YTD return | +27.24% | -16.84% |
| 1-year return | +28.73% | +51.07% |
| 5-year return | +155.92% | -21.29% |
| P/E ratio (TTM) | 20.90 | — |
| Forward P/E | 17.59 | — |
| EPS (TTM) | $6.56 | $-1.30 |
| Dividend yield | 0.58% | 0.00% |
| Annual dividend | $0.80 | $0.00 |
| Revenue (latest FY) | $1.65B | $211.08M |
| Revenue growth (YoY) | +4.58% | +27.14% |
| Net income (latest FY) | $317.26M | $-51.06M |
| Gross margin | 23.94% | 69.32% |
| Operating margin | 16.04% | -18.48% |
| Net margin | 19.23% | -24.19% |
| 52-week high | $162.20 | $97.59 |
| 52-week low | $94.61 | $38.38 |
| Distance from 52-week high | -15.46% | -37.13% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +19.59% | +66.98% |
| Average volume | 249.97K | 427.13K |
| Shares outstanding | 30.05M | 29.80M |
| Employees | 3,767 | 1,004 |
| Sector | Industrials | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AZZ is about 2.3 times larger than Establishment Labs by market value ($4.12B vs $1.83B).
- ESTA has outperformed AZZ by 22.3 percentage points over the past year.
- AZZ is more profitable, keeping 19.2 cents of every revenue dollar as net income versus -24.2 cents for Establishment Labs.
- Establishment Labs grew revenue faster in its latest fiscal year (+27.14% vs +4.58%).
- The two companies sit in different sectors: AZZ in Industrials and Establishment Labs in Health Care.
About AZZ
AZZ stock →AZZ Inc. provides hot-dip galvanizing and coil coating solutions in North America.
Industrials · Industrial Specialties · 3,767 employees
About Establishment Labs
ESTA stock →Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand.
Health Care · Industrial Specialties · 1,004 employees
AZZ vs ESTA FAQ
Which is bigger, AZZ or Establishment Labs?
AZZ (AZZ) is larger, with a market capitalization of $4.12B compared with $1.83B for Establishment Labs (ESTA).
Which stock has performed better over the past year, AZZ or ESTA?
ESTA returned +51.07% over the past 12 months, compared with +28.73% for AZZ (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, AZZ or Establishment Labs?
AZZ pays a dividend yielding 0.58%, while Establishment Labs does not currently pay a regular dividend.
Are AZZ and Establishment Labs in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Industrials sector.